GE HealthCare Technologies Inc. $GEHC Shares Purchased by Korea Investment CORP

Korea Investment CORP raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 68.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 309,501 shares of the company’s stock after purchasing an additional 125,879 shares during the period. Korea Investment CORP’s holdings in GE HealthCare Technologies were worth $22,925,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Allianz SE lifted its stake in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the period. Gladwyn Financial Advisors Inc. acquired a new position in GE HealthCare Technologies in the 2nd quarter valued at $34,000. Game Plan Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the last quarter. Zions Bancorporation National Association UT purchased a new position in shares of GE HealthCare Technologies during the 1st quarter worth $42,000. Finally, HFM Investment Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $60,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $79.99 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a 50 day moving average of $75.08 and a two-hundred day moving average of $74.16. The company has a market cap of $36.43 billion, a P/E ratio of 16.53, a P/E/G ratio of 3.34 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter last year, the firm posted $1.14 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Stifel Nicolaus set a $90.00 target price on GE HealthCare Technologies in a research note on Friday, November 21st. Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, November 17th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $86.45.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.